Valantine Hannah
CIK 1855608
Transactions on file
27
Open-market buys
3
Win rate (buys)
100%
3 scored
Avg % since filing (buys)
+443.9%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-17 | 2026-07-16 | CDNA CareDx, Inc. | Sale | 100 | $3.7K | +36.4% | open → | |
| 2026-07-17 | 2026-07-16 | CDNA CareDx, Inc. | Sale | 28,679 | $1.04M | +37.9% | open → | |
| 2026-07-17 | 2026-07-16 | CDNA CareDx, Inc. | Exer. | 5,125 | $40.8K | +526.4% | open → | |
| 2026-07-17 | 2026-07-16 | CDNA CareDx, Inc. | Exer. | 16,048 | $227.7K | +251.4% | open → | |
| 2026-07-17 | 2026-07-16 | CDNA CareDx, Inc. | Exer. | 7,606 | $156.4K | +142.5% | open → | |
| 2026-06-24 | 2026-06-23 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 2,196 | $150.6K | +5.7% | open → |
| 2026-06-24 | 2026-06-22 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 2,808 | $190.9K | +6.6% | open → |
| 2026-06-24 | 2026-06-22 | BBIO BridgeBio Pharma, Inc. | Director | Exer. | 2,808 | $117.2K | +73.7% | open → |
| 2026-06-24 | 2026-06-22 | BBIO BridgeBio Pharma, Inc. | Director | Grant | 3,990 | $0.00 | — | open → |
| 2026-06-16 | 2026-06-15 | CDNA CareDx, Inc. | Sale | 12,103 | $279.7K | +115.7% | open → | |
| 2026-06-16 | 2026-06-12 | CDNA CareDx, Inc. | Grant | 9,795 | $0.00 | — | open → | |
| 2025-03-10 | 2025-03-06 | BBIO BridgeBio Pharma, Inc. | Director | Exer. | 12,875 | $215.7K | +332.8% | open → |
| 2025-03-10 | 2025-03-06 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 12,875 | $419.5K | +122.5% | open → |
| 2025-06-11 | 2025-06-10 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 4,292 | $171.7K | +81.3% | open → |
| 2025-06-11 | 2025-06-10 | BBIO BridgeBio Pharma, Inc. | Director | Exer. | 4,292 | $71.9K | +332.8% | open → |
| 2025-06-17 | 2025-06-13 | CDNA CareDx, Inc. | Director | Grant | 12,103 | $0.00 | — | open → |
| 2025-06-23 | 2025-06-18 | CDNA CareDx, Inc. | Director | Sale | 10,570 | $202.5K | +160.2% | open → |
| 2025-06-24 | 2025-06-20 | BBIO BridgeBio Pharma, Inc. | Director | Grant | 6,589 | $0.00 | — | open → |
| 2025-06-30 | 2021-12-28 | BBIO BridgeBio Pharma, Inc. | Director | Buy | 796 | $10.5K | +450.9% | open → |
| 2025-06-30 | 2021-12-28 | BBIO BridgeBio Pharma, Inc. | Director | Buy | 1,542 | $19.6K | +471.8% | open → |
| 2025-06-30 | 2021-12-29 | BBIO BridgeBio Pharma, Inc. | Director | Buy | 1,752 | $24.9K | +409.1% | open → |
| 2025-06-30 | 2025-06-26 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 876 | $38.6K | +64.4% | open → |
| 2025-06-30 | 2025-06-26 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 1,542 | $67.9K | +64.7% | open → |
| 2025-06-30 | 2025-06-26 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 398 | $17.6K | +64.3% | open → |
| 2025-06-30 | 2025-06-26 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 1,891 | $83.3K | +64.7% | open → |
| 2025-11-14 | 2025-11-12 | BBIO BridgeBio Pharma, Inc. | Director | Sale | 25,484 | $1.68M | +9.7% | open → |
| 2025-11-14 | 2025-11-12 | BBIO BridgeBio Pharma, Inc. | Director | Exer. | 25,484 | $1.23M | +49.6% | open → |
